236 related articles for article (PubMed ID: 15807990)
1. Metabolism of pantoprazole involving conjugation with glutathione in rats.
Zhong D; Xie Z; Chen X
J Pharm Pharmacol; 2005 Mar; 57(3):341-9. PubMed ID: 15807990
[TBL] [Abstract][Full Text] [Related]
2. A metabolic route of omeprazole involving conjugation with glutathione identified in the rat.
Weidolf L; Karlsson KE; Nilsson I
Drug Metab Dispos; 1992; 20(2):262-7. PubMed ID: 1352219
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
Jin L; Baillie TA
Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana.
Xie ZY; Huang HH; Zhong DF
Xenobiotica; 2005 May; 35(5):467-77. PubMed ID: 16012078
[TBL] [Abstract][Full Text] [Related]
6. Apparent anaphylaxis associated with pantoprazole.
Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of pantoprazole in man.
Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
[TBL] [Abstract][Full Text] [Related]
8. Isolation and identification of the metabolites of paeonol in human urine.
Ding L; Liu Z; Zhao F; Bai G; Chen L; Yao X; Qiu F
Xenobiotica; 2012 Dec; 42(12):1206-12. PubMed ID: 22680310
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats.
Masubuchi N; Yamazaki H; Tanaka M
Chirality; 1998; 10(8):747-53. PubMed ID: 9803530
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel metabolic pathways of pioglitazone in hepatocytes: N-glucuronidation of thiazolidinedione ring and sequential ring-opening pathway.
Uchiyama M; Fischer T; Mueller J; Oguchi M; Yamamura N; Koda H; Iwabuchi H; Izumi T
Drug Metab Dispos; 2010 Jun; 38(6):946-56. PubMed ID: 20185540
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin.
Tanaka M; Ohkubo T; Otani K; Suzuki A; Kaneko S; Sugawara K; Ryokawa Y; Ishizaki T
Clin Pharmacol Ther; 2001 Mar; 69(3):108-13. PubMed ID: 11240974
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
15. Stability of pantoprazole in an extemporaneously compounded oral liquid.
Dentinger PJ; Swenson CF; Anaizi NH
Am J Health Syst Pharm; 2002 May; 59(10):953-6. PubMed ID: 12040734
[No Abstract] [Full Text] [Related]
16. Identification of two main urinary metabolites of [14C]omeprazole in humans.
Renberg L; Simonsson R; Hoffmann KJ
Drug Metab Dispos; 1989; 17(1):69-76. PubMed ID: 2566473
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an in vivo and in vitro study.
Yang B; Meng Z; Dong J; Yan L; Zou L; Tang Z; Dou G
Drug Metab Dispos; 2005 Jul; 33(7):930-6. PubMed ID: 15802385
[TBL] [Abstract][Full Text] [Related]
18. Identification of the metabolites of roxithromycin in humans.
Zhong D; Li X; Wang A; Xu Y; Wu S
Drug Metab Dispos; 2000 May; 28(5):552-9. PubMed ID: 10772634
[TBL] [Abstract][Full Text] [Related]
19. Metabolic studies of mesterolone in horses.
Ho EN; Leung DK; Leung GN; Wan TS; Wong HN; Xu X; Yeung JH
Anal Chim Acta; 2007 Jul; 596(1):149-55. PubMed ID: 17616252
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
